Skip to Content

Azelastine nasal Pregnancy and Breastfeeding Warnings

Azelastine nasal is also known as: Astelin, Astepro

Medically reviewed on Mar 9, 2018

Azelastine nasal Pregnancy Warnings

Animal studies have shown that this drug causes developmental toxicity in mice, rats, and rabbits at doses more than 15 times the equivalent human dose. Neither fetal nor maternal effects occurred at approximately 15 times the human dose or less. There are no adequate and well-controlled studies in pregnant women.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: C

See references

Azelastine nasal Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Yes (in small amounts)

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Astepro (azelastine nasal)." Meda Pharmaceuticals, Somerset, NJ.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. "Product Information. Astelin (azelastine)." Carter Products, Cranbury, NJ.

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  2. "Product Information. Astelin (azelastine)." Carter Products, Cranbury, NJ.
  3. "Product Information. Astepro (azelastine nasal)." Meda Pharmaceuticals, Somerset, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide